Lemonn Mobile Sticky Banner

Molbio Diagnostics IPO Allotment Status: How to Check, Final Subscription, and Listing Timeline

Prefer us on Google — Button Prefer us on Google
Molbio Diagnostics IPO Allotment Status: How to Check, Final Subscription, and Listing Timeline

The Molbio Diagnostics IPO allotment is expected to be finalised on 13 August 2026. Investors who applied for the ₹939.70 crore book-built mainboard IPO should use KFin Technologies Limited’s website as the primary channel to check allotment status, with the BSE and NSE application-status pages as additional verification routes.

The issue received a strong response, with the final overall subscription reported at about 70.26 times. Qualified institutional buyers (QIBs) led demand at 186.39 times, followed by non-institutional investors (NIIs) at 49.80 times, while retail individual investors (RIIs) and the employee category were subscribed 12.96 times and 13.28 times, respectively. The unofficial grey market premium (GMP) was ₹138 per share, or about 17.1% over the upper issue price of ₹807, as of early afternoon (12:00 noon to 1:59 p.m. IST) on 12 August 2026, suggesting firm unofficial sentiment.

Molbio Diagnostics IPO Allotment Status: Latest Update

Molbio Diagnostics Limited closed its IPO for subscription on 12 August 2026, and the basis of allotment is scheduled for 13 August 2026. Until the allocation process is completed and the registrar makes the data searchable, applicants should treat the allotment as expected rather than finalised.

KFin Technologies Limited is the registrar to the issue. The IPO had a price band of ₹768 to ₹807 per share and a lot size of 18 shares. It is scheduled to list on both BSE and NSE.

An application or bid appearing on an exchange portal confirms that bidding details were captured. It does not, by itself, confirm that shares have been allotted.

Molbio Diagnostics IPO Allotment and Listing Timeline

EventDateWhat it means
IPO closed12 August 2026New bids are no longer accepted
Basis of allotment13 August 2026Share allocation is expected to be finalised
Fund debit or unblocking14 August 2026Payable amount may be debited and excess or unsuccessful application funds unblocked
Demat credit14 August 2026Allotted shares are scheduled to reach demat accounts
Listing17 August 2026Shares are scheduled to begin trading on BSE and NSE

These dates reflect the announced IPO schedule. Banking or demat account displays can sometimes update after the underlying processing has been completed.

What You Need to Check the Allotment

Keep your IPO application details ready before checking. KFin Technologies’ allotment portal supports identifiers such as:

  • Permanent Account Number (PAN)
  • Application number
  • Demat account details

Use the same information submitted with your IPO application. Checking allotment status should not require a one-time password (OTP), Unified Payments Interface (UPI) PIN, bank password, or trading password.

How to Check Molbio Diagnostics IPO Allotment Status

Check on the Official Registrar Website

The registrar is the primary source for final allotment information.

  1. Open the KFin Technologies IPO allotment-status page.
  2. Select Molbio Diagnostics Limited when the issue becomes available in the IPO list.
  3. Choose the permitted search method, such as application number, demat account, or PAN.
  4. Enter the requested details exactly as submitted in the application.
  5. Complete the verification or captcha shown on the page.
  6. Submit the form to view the allotment result once the allocation data is live.

If Molbio Diagnostics does not yet appear in the selectable issue list, or the portal does not return an allocation result, the allotment data may still be under processing.

Check on BSE

Applicants can also use the BSE Status of Issue Application page as an additional verification route.

Select equity as the issue type, choose Molbio Diagnostics, and enter either the application number or PAN along with the captcha.

BSE can display application information and, after the registrar completes allocation, allotment details supplied by the registrar. A successful application record before that stage should not be interpreted as confirmation of allotment.

Check on NSE

The NSE IPO Bid and Allotment Verification page provides another official route.

Applicants can use PAN or application details as supported by the facility. NSE’s bid-verification function helps confirm whether application information was uploaded to the exchange system and can subsequently display allotment information provided by the registrar.

What Does Your IPO Allotment Status Mean?

StatusMeaningWhat to do
AllottedShares have been allocated to your applicationCheck the quantity and monitor your demat account
Not allottedNo shares were allocatedMonitor your bank account for release of blocked funds
Pending or under processAllocation data is not yet final or updatedCheck again after processing is completed
No record foundThe portal cannot match the details enteredRecheck the issue name and application identifiers

“No record found” does not automatically mean rejection. It can result from an incorrect PAN or application number, an issue-selection error, a data-update delay, or a problem with the original application.

Molbio Diagnostics IPO Final Subscription

Final bidding data showed broad oversubscription across investor categories.

Investor categoryFinal subscription
Qualified institutional buyers186.39 times
Non-institutional investors49.80 times
Retail individual investors12.96 times
Employees13.28 times
Overall70.26 times

For a retail applicant, the relevant demand figure is the 12.96-times retail subscription, not the 70.26-times headline number. Oversubscription indicates that demand exceeded the shares available in that category, but it does not establish an exact individual allotment probability.

The unofficial GMP is also separate from the allotment process. It can change quickly and is not a guaranteed indicator of the eventual listing price or return.

What Happens After IPO Allotment?

If Shares Are Allotted

For an application made through the Application Supported by Blocked Amount (ASBA) process, the amount payable for allotted shares is debited from the blocked application funds. Any excess blocked amount is released.

The allotted shares are scheduled to be credited to the applicant’s demat account on 14 August 2026. Once credited, verify that the quantity matches the final allotment shown by the registrar.

If Shares Are Not Allotted

If no shares are allotted, the blocked application amount should be released rather than treated as a separate fresh payment from the issuer.

A bank may take additional time to reflect the released balance even after the unblock instruction has been processed. An approved UPI mandate only confirms the fund-blocking step and does not prove that shares were allotted.

Allotment Not Showing or Funds Still Blocked?

First confirm that the allotment process has actually been finalised. Checking too early is a common reason for a missing result.

If the result should already be available:

  • Recheck the selected issue name, PAN, application number, and demat details.
  • Confirm that the IPO bid was successfully captured.
  • Consider whether there was an application issue, such as a PAN mismatch, duplicate application, unsuccessful mandate, or incompatible payment details.
  • Contact the registrar for allotment-result discrepancies.
  • Contact your bank or self-certified syndicate bank for delayed release of blocked funds.
  • Contact your broker if the concern relates to order routing or the application number shown in its records.

Do not share your UPI PIN, bank password, trading password, or other authentication credentials while seeking assistance.

Bottom Line

Molbio Diagnostics IPO allotment is scheduled to be finalised on 13 August 2026, with KFin Technologies as the primary status-checking channel. Applicants should verify the final registrar result rather than relying on bid confirmation or UPI mandate approval, then monitor fund processing and demat credit scheduled for 14 August ahead of the 17 August listing.

Frequently Asked Questions (FAQs)

Q: Is Molbio Diagnostics IPO allotment out?

A: The allotment is expected to be finalised on 13 August 2026. Until the registrar completes the allocation process and searchable results become available, applicants should not treat the allotment as finalised.

Q: Where can I check Molbio Diagnostics IPO allotment status officially?

A: KFin Technologies Limited, the registrar, is the primary official checking channel. BSE and NSE also provide application or bid verification facilities and can display allotment information after it is supplied by the registrar.

Q: Can I check Molbio Diagnostics IPO allotment using PAN?

A: Yes. The registrar’s allotment-status facility supports PAN as one of its search identifiers. Enter the same PAN used in the IPO application.

Q: What does “no record found” mean on the allotment page?

A: It does not necessarily mean that your application was rejected. The result may not yet be live, or the issue name, PAN, application number, or demat information may have been entered incorrectly.

Q: Does an approved UPI mandate mean I received an allotment?

A: No. UPI mandate approval confirms that the application funds were authorised for blocking. Final share allocation is confirmed only through the completed allotment result.

Q: When will Molbio Diagnostics IPO funds be unblocked and shares credited?

A: Fund debit or unblocking and demat credit are scheduled for 14 August 2026. The bank or demat account interface may sometimes reflect the completed processing with a delay.

Q: Does 12.96-times retail subscription mean every retail applicant has the same allotment chance?

A: No. The retail subscription multiple shows aggregate demand compared with shares available to retail investors. It should not be converted into an exact individual allotment probability without the final official basis-of-allotment information.

Disclaimer

The stocks mentioned in this article are not recommendations. Please conduct your own research and due diligence before investing. Investment in securities market are subject to market risks, read all the related documents carefully before investing. Please read the Risk Disclosure documents carefully before investing in Equity Shares, Derivatives, Mutual fund, and/or other instruments traded on the Stock Exchanges. As investments are subject to market risks and price fluctuation risk, there is no assurance or guarantee that the investment objectives shall be achieved. Lemonn (Formerly known as NU Investors Technologies Pvt. Ltd) do not guarantee any assured returns on any investments. Past performance of securities/instruments is not indicative of their future performance.

Sleek Sticky Registration Footer